Compare GENC & LFMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GENC | LFMD |
|---|---|---|
| Founded | N/A | 1994 |
| Country | United States | United States |
| Employees | N/A | 384 |
| Industry | Construction/Ag Equipment/Trucks | Medical/Nursing Services |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 232.2M | 236.7M |
| IPO Year | 1995 | N/A |
| Metric | GENC | LFMD |
|---|---|---|
| Price | $14.92 | $4.99 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 7 |
| Target Price | ★ $17.60 | $9.14 |
| AVG Volume (30 Days) | 18.0K | ★ 1.1M |
| Earning Date | 02-06-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 8.08 | N/A |
| EPS | ★ 0.23 | N/A |
| Revenue | ★ $48,943,000.00 | N/A |
| Revenue This Year | N/A | $17.52 |
| Revenue Next Year | $25.51 | $18.73 |
| P/E Ratio | $65.13 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $12.00 | $2.60 |
| 52 Week High | $17.40 | $15.34 |
| Indicator | GENC | LFMD |
|---|---|---|
| Relative Strength Index (RSI) | 48.25 | 66.90 |
| Support Level | $14.62 | $3.39 |
| Resistance Level | $15.40 | $6.49 |
| Average True Range (ATR) | 0.35 | 0.40 |
| MACD | -0.02 | 0.05 |
| Stochastic Oscillator | 29.83 | 91.07 |
Gencor Industries Inc and its subsidiaries are a manufacturer of heavy machinery used in the production of highway construction materials and environmental control equipment. The Company's products are manufactured in the United States and sold through a combination of Company sales representatives and independent dealers and agents. The Company has one reporting segment, equipment for the highway construction industry. The Company's principal core products include asphalt pavers, hot mix asphalt plants, combustion systems, and fluid heat transfer systems. It operates in the United States, Canada, and other foreign countries, with the majority of revenue coming from the United States.
LifeMD Inc is a patient-centric, direct-to-patient healthcare company providing a high-quality, cost-effective, and convenient way for patients to access virtual medical care and pharmacy services. The Company's portfolio of brands within continuing operations is now managed as a single operating segment, Telehealth. Telehealth platform integrates core capabilities, includes: A nationwide pharmacy network, A wholly-owned commercial pharmacy, A fully integrated patient care center, A direct-to-patient marketing infrastructure for acquisition and retention, and AI-enabled clinical and operational technologies.